New registry aims to uncover heart risks in inflammatory disease patients

NCT ID NCT06478277

Recruiting now Knowledge-focused Sponsor: University of Manchester Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is building a large group of 600 people with immune-mediated inflammatory diseases (like arthritis or lupus) to track their heart health over time. Researchers will use simple blood tests to see if certain heart-related markers can predict future heart problems. The goal is to better understand and manage cardiovascular risks in these patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry could help doctors better predict heart problems in people with inflammatory diseases, leading to earlier prevention.
What could go wrong: This is an observational study, not a treatment trial. It collects data but does not test any intervention, so it cannot directly improve health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder inflammatory disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR DISEASES IMMUNE-MEDIATED INFLAMMATORY DISEASES

Contacts and locations

Locations

Countess of Chester Hospital NHS Foundation Trust
RECRUITING

Chester, CH2 1UL, United Kingdom
Royal Infirmary of Edinburgh
RECRUITING

Edinburgh, Scotland, EH16 4SA, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.